Informație de încredere. Sprijin real.

Ai întrebări despre autism, ADHD, anxietate sau depresie? Găsești ghiduri clare, verificate de specialiști. Acum, acces gratuit.

Spațiu publicitar disponibil — bannerul mare de susSpațiu publicitar disponibil — bannerul mare de sus

Explorează temele

Caută tot →

Sănătate mintală și neurodezvoltare

Afecțiuni neurologice

Articole și ghiduri recomandate

StudiuParkinsonÎncredere bună27.06.2026

Multi-session neurofeedback with implanted deep brain stimulation electrodes in Parkinson's disease patients

This exploratory study investigated the feasibility of repeated neurofeedback sessions using implanted DBS systems in 8 Parkinson's disease patients, where real-time visual feedback of beta oscillations from the subthalamic nucleus allowed patients to attempt regulation of neural activity across three separate days. Results showed significant beta power reduction in sessions 1 and 3, with dopaminergic medication negatively impacting downregulation performance while DBS stimulation enhanced it.

StudiuParkinsonÎncredere înaltă27.06.2026

Glucagon-like peptide-1 receptor agonists in movement disorders: Mechanisms, evidence, and future directions

GLP-1 receptor agonists, originally developed for diabetes and obesity, show neuroprotective properties in preclinical models of movement disorders by modulating neuroinflammation, oxidative stress, and protein aggregation. Clinical evidence is most advanced in Parkinson's disease, though early promise from exenatide and lixisenatide trials was not confirmed in larger phase III studies, with preliminary signals emerging in other movement disorders.

StudiuParkinsonÎncredere înaltă23.06.2026

Brain Cholinergic Imaging in Isolated REM Sleep Behavior Disorder: Distinctions and Similarities with Parkinson's Disease

This PET neuroimaging study examined cholinergic terminal density in 16 patients with isolated REM sleep behavior disorder (iRBD, a prodromal stage of Parkinson's disease) compared to 12 Parkinson's patients and 18 controls. Both patient groups showed similar cortical cholinergic denervation (11-12% reduction) with distinct regional patterns, while iRBD showed associations between lower cholinergic uptake and impaired executive/visuospatial function.

StudiuParkinsonÎncredere înaltă23.06.2026

POLG-associated Parkinson's disease-ALS overlap: Novel variant and first use of continuous subcutaneous foslevodopa/foscarbidopa infusion

A 38-year-old patient with a rare POLG gene variant developed an unusual overlap syndrome combining young-onset Parkinson's disease with ALS-like features (Brait-Fahn-Schwartz disease). Continuous subcutaneous infusion of foslevodopa/foscarbidopa achieved significant motor improvement at twelve months, representing the first documented use of this device-based therapy in this genetic condition.